328
Participants
Start Date
February 18, 2003
Primary Completion Date
January 27, 2004
tipranavir
ritonavir
saquinavir
amprenavir
lopinavir
Boehringer Ingelheim Investigational Site, Phoenix
Boehringer Ingelheim Investigational Site, Berkeley
Boehringer Ingelheim Investigational Site, Fountain Valley
Boehringer Ingelheim Investigational Site, Los Angeles
Boehringer Ingelheim Investigational Site, San Francisco
Kaiser Permanente Medical Center, San Francisco
San Francisco VAMC, San Francisco
Boehringer Ingelheim Investigational Site, Norwalk
Washington DC VA Medical Center, Washington D.C.
North Broward Hospital District, Fort Lauderdale
Boehringer Ingelheim Investigational Site, Fort Myers
Boehringer Ingelheim Investigational Site, Miami
Boehringer Ingelheim Investigational Site, Orlando
Boehringer Ingelheim Investigational Site, Sarasota
Boehringer Ingelheim Investigational Site, Tampa
Boehringer Ingelheim Investigational Site, Vero Beach
Boehringer Ingelheim Investigational Site, Atlanta
Mercer University School of Medicine, Macon
University of Kentucky Medical Center, Lexington
Boehringer Ingelheim Investigational Site, Boston
Brigham and Women's Hospital, Boston
Boehringer Ingelheim Investigational Site, Springfield
Henry Ford Hospital, Detroit
Boehringer Ingelheim Investigational Site, Santa Fe
Albany Medical College, Albany
Boehringer Ingelheim Investigational Site, New York
University of New York, Stony Brook, Stony Brook
Duke University Medical Center, Durham
Boehringer Ingelheim Investigational Site, Huntersville
University of Pennsylvania, Philadelphia
UT Southwestern, Dallas
Boehringer Ingelheim Investigational Site, Houston
Boehringer Ingelheim Investigational Site, Annandale
Boehringer Ingelheim Investigational Site, Tacoma
Boehringer Ingelheim Investigational Site, Darlinghurst
St. Vincent's Hospital, Darlinghurst
Instituut Tropische Geneeskunde, Antwerp
Centre Hospitalier Universitaire St. Pierre, Brussels
U.Z. Gent, Ghent
McMaster University Medical Centre, Hamilton
Boehringer Ingelheim Investigational Site, Toronto
Canadian Immunodeficiency Research Collaborative Inc., Toronto
Toronto General Hospital, Toronto
McGill University Health Centre, Suite A5-140, Monteal
Boehringer Ingelheim Investigational Site, Montreal
Montreal Chest Institute - McGill University Health Centre, Montreal
Hvidovre Hospital, Hvidovre
Rigshospitalet, København Ø
Odense Universitetshospital, Odense C
Hôpital Pellegrin, Bordeaux
Hôpital Côte de Nacre, Caen
Hôpital Antoine Beclère, Clamart
Hôpital de l'Hôtel Dieu, Lyon
Hôpital Hôtel Dieu, Nantes
Hôpital de l'Archet, Nice
Hôpital Bichat Claude Bernard, Paris
Hôpital de la Pité Salpêtrière, Paris
Hôpital Européen Georges Pompidou, Paris
Hôpital Saint Antoine, Paris
Hôpital de Pontchaillou, Rennes
Hôpital civil, Strasbourg
Hôpital brabois, Vandœuvre-lès-Nancy
Hôpital Paul Brousse, Villejuif
Boehringer Ingelheim Investigational Site, Aachen
Epimed GmbH, Berlin
Universitätsklinikum Charité, Berlin
Medizinische Universitätsklinik Bonn, Bonn
Klinik I für Innere Medizin der, Cologne
Boehringer Ingelheim Investigational Site, Düsseldorf
Universitätsklinikum Düsseldorf, Düsseldorf
Universitätsklinik Erlangen-Nürnberg, Erlangen
Universitätsklinikum Essen, Essen
Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main
Boehringer Ingelheim Investigational Site, Freiburg im Breisgau
Universitätsklinkum Freiburg, Freiburg im Breisgau
ifi Institut für interdisziplinäre Infektiologie, Hamburg
Universitätsklinik Hamburg-Eppendorf, Hamburg
Med. Hochschule Hannover, Hanover
Universitätsklinikum Heidelberg, Heidelberg
Facharzt für Innere Medizin,, Mannheim
Boehringer Ingelheim Investigational Site, München
Medizinische Poliklinik, München
Klinium Natruper Holz, Osnabrück
Boehringer Ingelheim Investigational Site, Stuttgart
1st Social Insurance Foundation (IKA) Pentelis, Athens
Andreas Syggros Hosp., Athens
Evangelismos Hospital, Athens
"General Hospital G. Gennimatas", Athens
Korgialenio-Benakio-Hellenic Red Cross General Hospital, Athens
Sismanoglio Hospital, Athens
University Hospital of Patras, Pátrai
"Tzanio Hospital", Piraeus
AHEPA Hospital, Thessaloniki
Fondazione S. Raffaele del Monte Tabor, Milan
Ospedale Amedeo di Savoia, Torino
OLVG, Amsterdam
Slotervaart Hospital, Amsterdam
Erasmus Medical Centre, Rotterdam
Medical Centre Haaglanden, The Hague
Hospital Condes Castro Guimarães, Cascais
Hospitais da Universidade de Coimbra, Coimbra
Department of Infeccious Diseases, Lisbon
Hospital de São João, Porto
Universitätsspital Basel, Basel
Kantonsspital St. Gallen, Sankt Gallen
Universitätsspital Zürich, Zurich
Royal Free Hospital, London
SSAT/Crusaid Institute, London
St Mary's Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY